Ophthalmology, Retina Specialist · Santa Barbara, CA
NPI
1508070566
Since 2007
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
525 E Micheltorena St Ste A
Santa Barbara, CA, 93103
Phone (805) 963-1648
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.0M
63,150 services
Medicare patients, 2024
1,922
Average age 75
Drug cost, 2024
$76K
1,727 prescriptions
Company payments, 2025
$302K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dilsher S Dhoot was code J2777 (injection, faricimab-svoa, 0.1 mg), 36,600 times for 166 patients. In total Dilsher S Dhoot billed 63,150 services in 55 codes, and Medicare paid $6.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 36,600 | 166 | $27.44 | $1.0M |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 4,410 | 51 | $117.15 | $517K |
| 92134 Computerized Ophthalmic Imaging | Office | 3,827 | 1,541 | $33.22 | $127K |
| Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2,993 | 230 | $185.26 | $554K |
| 67028 Intravitreal Injection | Office | 2,871 | 769 | $108.78 | $312K |
| J0178 Injection, aflibercept, 1 mg | Office | 2,838 | 359 | $658.00 | $1.9M |
| J0177 Injection, aflibercept hd, 1 mg | Office | 2,392 | 102 | $263.50 | $630K |
| 92012 Ophthalmological E&M | Office | 1,636 | 719 | $69.09 | $113K |
| 92014 Ophthalmological E&M | Office | 1,422 | 1,052 | $97.24 | $138K |
| 92250 Angiography | Office | 918 | 741 | $28.55 | $26K |
| Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 770 | 54 | $131.98 | $102K |
| 92202 Ophthalmological E&M | Office | 318 | 289 | $11.99 | $3,811 |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 210 | 18 | $161.18 | $34K |
| 92004 Ophthalmological E&M | Office | 167 | 167 | $119.25 | $20K |
| 99204 Office E&M - New | Office | 150 | 150 | $135.36 | $20K |
By year: 2022 $5.1M for 22,959 services; 2023 $5.5M for 42,962 services; 2024 $6.0M for 63,150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dilsher S Dhoot prescribed most often to Medicare patients was Prednisolone Acetate, with 343 prescriptions and refills. In total Dilsher S Dhoot wrote 1,727 Medicare prescriptions that cost $76K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 343 | 525 | 185 | $15K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 249 | 590 | 100 | $3,465 |
| Ketorolac Tromethamine Generic | 171 | 252 | 70 | $5,152 |
| Erythromycin Erythromycin Base | 165 | 165 | 117 | $1,725 |
| Atropine Sulfate Generic | 143 | 189 | 97 | $6,709 |
| Brimonidine Tartrate Generic | 137 | 282 | 56 | $4,023 |
| Latanoprost Generic | 117 | 205 | 44 | $653 |
| Ciprofloxacin Hcl Generic | 101 | 117 | 80 | $1,536 |
| Timolol Maleate Generic | 42 | 108 | 20 | $363 |
| Dorzolamide Hcl Generic | 23 | 47 | 14 | $437 |
| Moxifloxacin Moxifloxacin Hcl | 21 | 22 | 12 | $538 |
| Travoprost Generic | 17 | 23 | Under 11 | $1,944 |
| Ofloxacin Generic | 17 | 19 | 11 | $193 |
| Fluorometholone Generic | 16 | 21 | Under 11 | $1,478 |
| Loteprednol Etabonate Generic | 15 | 23 | Under 11 | $3,410 |
Brand drugs: 603 claims; generic drugs: 1,124 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dilsher S Dhoot $302K ($277K in general payments such as food, travel and fees and $25K for research) from 18 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $108K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 85 | $108K |
| Apellis Pharmaceuticals, Inc. APLS | 63 | $68K |
| Ocular Therapeutix, Inc. OCUL | 50 | $64K |
| ANI Pharmaceuticals, Inc. ANIP | 16 | $19K |
| Bausch & Lomb Americas Inc. BLCO | 9 | $12K |
| Regeneron Pharmaceuticals, Inc. REGN | 6 | $11K |
| Genentech USA, Inc. ROG.SW | 12 | $7,689 |
| Genentech, Inc. ROG.SW | 3 | $4,060 |
| Astellas Pharma Global Development 4503.T | 1 | $3,692 |
| Roche Products Limited ROG.SW | 1 | $3,150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.